APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sodium Iodine (131I) Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Sodium Iodine (131I) Drugs Market Outlook and Growth Opportunities 2026

22 December 2025190 pages

Choose your research edition.

Industry ResearchSodium Iodine (131I) Drugs Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Sodium Iodine (131I) Drugs Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Sodium Iodine (131I) Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sodium Iodine (131I) Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Sodium Iodine (131I) Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Sodium Iodine (131I) Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Sodium Iodine (131I) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sodium Iodine (131I) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sodium Iodine (131I) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Sodium Iodine (131I) Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Sodium Iodine (131I) Drugs market include Hta Co., Ltd, Yantai Dongcheng Biochemicals Co.,Ltd., Chengdu Gaotong Isotope Co.,Ltd., Mallinckrodt, Jubilant Radiopharma, International Isotopes, BWXT Medical Ltd, Bracco and AnazaoHealth, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sodium Iodine (131I) Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sodium Iodine (131I) Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sodium Iodine (131I) Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sodium Iodine (131I) Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Sodium Iodine (131I) Drugs Segment by Company

Hta Co., Ltd

Yantai Dongcheng Biochemicals Co.,Ltd.

Chengdu Gaotong Isotope Co.,Ltd.

Mallinckrodt

Jubilant Radiopharma

International Isotopes

BWXT Medical Ltd

Bracco

AnazaoHealth

Sodium Iodine (131I) Drugs Segment by Type

Sodium Iodine [131I] Capsules

Sodium iodine [131I] Oral Solution

Sodium Iodine (131I) Drugs Segment by Application

Diagnosis and Investigation

Thyroid Cancer

Hyperthyroidism

Sodium Iodine (131I) Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Sodium Iodine (131I) Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Sodium Iodine (131I) Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sodium Iodine (131I) Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Sodium Iodine (131I) Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sodium Iodine (131I) Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sodium Iodine (131I) Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sodium Iodine (131I) Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sodium Iodine (131I) Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sodium Iodine (131I) Drugs industry.

Chapter 3: Detailed analysis of Sodium Iodine (131I) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Sodium Iodine (131I) Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Sodium Iodine (131I) Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sodium Iodine (131I) Drugs Industry Trends Table 2. Sodium Iodine (131I) Drugs Industry Drivers Table 3. Sodium Iodine (131I) Drugs Industry Opportunities and Challenges Table 4. Sodium Iodine (131I) Drugs Industry Restraints Table 5. Global Sodium Iodine (131I) Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sodium Iodine (131I) Drugs Revenue Share by Company (2021-2026) Table 7. Global Sodium Iodine (131I) Drugs Sales Volume by Company (k units) & (2021-2026) Table 8. Global Sodium Iodine (131I) Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Sodium Iodine (131I) Drugs Average Price (US$/unit) of Company (2021-2026) Table 10. Global Sodium Iodine (131I) Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Sodium Iodine (131I) Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Sodium Iodine (131I) Drugs Company, Product Type & Application Table 13. Global Sodium Iodine (131I) Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Sodium Iodine (131I) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Sodium Iodine [131I] Capsules Table 18. Significant Companies of Sodium iodine [131I] Oral Solution Table 19. Global Sodium Iodine (131I) Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Sodium Iodine (131I) Drugs Sales Volume by Type (2021-2026) & (k units) Table 21. Global Sodium Iodine (131I) Drugs Sales Volume by Type (2027-2032) & (k units) Table 22. Global Sodium Iodine (131I) Drugs Sales Volume Share by Type (2021-2026) Table 23. Global Sodium Iodine (131I) Drugs Sales Volume Share by Type (2027-2032) Table 24. Global Sodium Iodine (131I) Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Sodium Iodine (131I) Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Sodium Iodine (131I) Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Sodium Iodine (131I) Drugs Sales Value Share by Type (2021-2026) Table 28. Global Sodium Iodine (131I) Drugs Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Diagnosis and Investigation Table 30. Significant Companies of Thyroid Cancer Table 31. Significant Companies of Hyperthyroidism Table 32. Global Sodium Iodine (131I) Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Sodium Iodine (131I) Drugs Sales Volume by Application (2021-2026) & (k units) Table 34. Global Sodium Iodine (131I) Drugs Sales Volume by Application (2027-2032) & (k units) Table 35. Global Sodium Iodine (131I) Drugs Sales Volume Share by Application (2021-2026) Table 36. Global Sodium Iodine (131I) Drugs Sales Volume Share by Application (2027-2032) Table 37. Global Sodium Iodine (131I) Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Sodium Iodine (131I) Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Sodium Iodine (131I) Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Sodium Iodine (131I) Drugs Sales Value Share by Application (2021-2026) Table 41. Global Sodium Iodine (131I) Drugs Sales Value Share by Application (2027-2032) Table 42. Global Sodium Iodine (131I) Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Sodium Iodine (131I) Drugs Sales by Region (2021-2026) & (k units) Table 44. Global Sodium Iodine (131I) Drugs Sales Market Share by Region (2021-2026) Table 45. Global Sodium Iodine (131I) Drugs Sales by Region (2027-2032) & (k units) Table 46. Global Sodium Iodine (131I) Drugs Sales Market Share by Region (2027-2032) Table 47. Global Sodium Iodine (131I) Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Sodium Iodine (131I) Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Sodium Iodine (131I) Drugs Sales Value Share by Region (2021-2026) Table 50. Global Sodium Iodine (131I) Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Sodium Iodine (131I) Drugs Sales Value Share by Region (2027-2032) Table 52. Global Sodium Iodine (131I) Drugs Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Sodium Iodine (131I) Drugs Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Sodium Iodine (131I) Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Sodium Iodine (131I) Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Sodium Iodine (131I) Drugs Sales by Country (2021-2026) & (k units) Table 57. Global Sodium Iodine (131I) Drugs Sales Market Share by Country (2021-2026) Table 58. Global Sodium Iodine (131I) Drugs Sales by Country (2027-2032) & (k units) Table 59. Global Sodium Iodine (131I) Drugs Sales Market Share by Country (2027-2032) Table 60. Global Sodium Iodine (131I) Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Sodium Iodine (131I) Drugs Sales Value Market Share by Country (2021-2026) Table 62. Global Sodium Iodine (131I) Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Sodium Iodine (131I) Drugs Sales Value Market Share by Country (2027-2032) Table 64. Hta Co., Ltd Company Information Table 65. Hta Co., Ltd Business Overview Table 66. Hta Co., Ltd Sodium Iodine (131I) Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Hta Co., Ltd Sodium Iodine (131I) Drugs Product Portfolio Table 68. Hta Co., Ltd Recent Development Table 69. Yantai Dongcheng Biochemicals Co.,Ltd. Company Information Table 70. Yantai Dongcheng Biochemicals Co.,Ltd. Business Overview Table 71. Yantai Dongcheng Biochemicals Co.,Ltd. Sodium Iodine (131I) Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Yantai Dongcheng Biochemicals Co.,Ltd. Sodium Iodine (131I) Drugs Product Portfolio Table 73. Yantai Dongcheng Biochemicals Co.,Ltd. Recent Development Table 74. Chengdu Gaotong Isotope Co.,Ltd. Company Information Table 75. Chengdu Gaotong Isotope Co.,Ltd. Business Overview Table 76. Chengdu Gaotong Isotope Co.,Ltd. Sodium Iodine (131I) Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Chengdu Gaotong Isotope Co.,Ltd. Sodium Iodine (131I) Drugs Product Portfolio Table 78. Chengdu Gaotong Isotope Co.,Ltd. Recent Development Table 79. Mallinckrodt Company Information Table 80. Mallinckrodt Business Overview Table 81. Mallinckrodt Sodium Iodine (131I) Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Mallinckrodt Sodium Iodine (131I) Drugs Product Portfolio Table 83. Mallinckrodt Recent Development Table 84. Jubilant Radiopharma Company Information Table 85. Jubilant Radiopharma Business Overview Table 86. Jubilant Radiopharma Sodium Iodine (131I) Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Jubilant Radiopharma Sodium Iodine (131I) Drugs Product Portfolio Table 88. Jubilant Radiopharma Recent Development Table 89. International Isotopes Company Information Table 90. International Isotopes Business Overview Table 91. International Isotopes Sodium Iodine (131I) Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. International Isotopes Sodium Iodine (131I) Drugs Product Portfolio Table 93. International Isotopes Recent Development Table 94. BWXT Medical Ltd Company Information Table 95. BWXT Medical Ltd Business Overview Table 96. BWXT Medical Ltd Sodium Iodine (131I) Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. BWXT Medical Ltd Sodium Iodine (131I) Drugs Product Portfolio Table 98. BWXT Medical Ltd Recent Development Table 99. Bracco Company Information Table 100. Bracco Business Overview Table 101. Bracco Sodium Iodine (131I) Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Bracco Sodium Iodine (131I) Drugs Product Portfolio Table 103. Bracco Recent Development Table 104. AnazaoHealth Company Information Table 105. AnazaoHealth Business Overview Table 106. AnazaoHealth Sodium Iodine (131I) Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. AnazaoHealth Sodium Iodine (131I) Drugs Product Portfolio Table 108. AnazaoHealth Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Sodium Iodine (131I) Drugs Distributors List Table 112. Sodium Iodine (131I) Drugs Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Sodium Iodine (131I) Drugs Product Image Figure 2. Global Sodium Iodine (131I) Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sodium Iodine (131I) Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Sodium Iodine (131I) Drugs Sales (2021-2032) & (k units) Figure 5. Global Sodium Iodine (131I) Drugs Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Sodium Iodine (131I) Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Sodium Iodine [131I] Capsules Image Figure 10. Sodium iodine [131I] Oral Solution Image Figure 11. Global Sodium Iodine (131I) Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Sodium Iodine (131I) Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Sodium Iodine (131I) Drugs Sales Volume Share by Type (2021-2032) Figure 14. Global Sodium Iodine (131I) Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Sodium Iodine (131I) Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Sodium Iodine (131I) Drugs Sales Value Share by Type (2021-2032) Figure 17. Diagnosis and Investigation Image Figure 18. Thyroid Cancer Image Figure 19. Hyperthyroidism Image Figure 20. Global Sodium Iodine (131I) Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Sodium Iodine (131I) Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Sodium Iodine (131I) Drugs Sales Volume Share by Application (2021-2032) Figure 23. Global Sodium Iodine (131I) Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Sodium Iodine (131I) Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Sodium Iodine (131I) Drugs Sales Value Share by Application (2021-2032) Figure 26. Global Sodium Iodine (131I) Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Sodium Iodine (131I) Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Sodium Iodine (131I) Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Sodium Iodine (131I) Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Sodium Iodine (131I) Drugs Sales Value (2021-2032) & (US$ Million) Figure 31. North America Sodium Iodine (131I) Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Sodium Iodine (131I) Drugs Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Sodium Iodine (131I) Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Sodium Iodine (131I) Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Sodium Iodine (131I) Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Sodium Iodine (131I) Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. South America Sodium Iodine (131I) Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Sodium Iodine (131I) Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Sodium Iodine (131I) Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Sodium Iodine (131I) Drugs Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Sodium Iodine (131I) Drugs Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Sodium Iodine [131I] Capsules
  • Sodium iodine [131I] Oral Solution
Applications
  • Diagnosis and Investigation
  • Thyroid Cancer
  • Hyperthyroidism
Companies covered
  • Hta Co., Ltd
  • Yantai Dongcheng Biochemicals Co.,Ltd.
  • Chengdu Gaotong Isotope Co.,Ltd.
  • Mallinckrodt
  • Jubilant Radiopharma
  • International Isotopes
  • BWXT Medical Ltd
  • Bracco
  • AnazaoHealth

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sodium Iodine (131I) Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Sodium Iodine (131I) Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Sodium Iodine (131I) Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Sodium Iodine (131I) Drugs Market Dynamics
  1. 2.1 Sodium Iodine (131I) Drugs Industry Trends
  2. 2.2 Sodium Iodine (131I) Drugs Industry Drivers
  3. 2.3 Sodium Iodine (131I) Drugs Industry Opportunities and Challenges
  4. 2.4 Sodium Iodine (131I) Drugs Industry Restraints
3 Sodium Iodine (131I) Drugs Market by Company
  1. 3.1 Global Sodium Iodine (131I) Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Sodium Iodine (131I) Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Sodium Iodine (131I) Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Sodium Iodine (131I) Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Sodium Iodine (131I) Drugs Company Ranking (2024-2026)
  6. 3.6 Global Sodium Iodine (131I) Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Sodium Iodine (131I) Drugs Company Product Type and Application
  8. 3.8 Global Sodium Iodine (131I) Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Sodium Iodine (131I) Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Sodium Iodine (131I) Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Sodium Iodine (131I) Drugs Market by Type
  1. 4.1 Sodium Iodine (131I) Drugs Type Introduction
  2. 4.1.1 Sodium Iodine [131I] Capsules
  3. 4.1.2 Sodium iodine [131I] Oral Solution
  4. 4.2 Global Sodium Iodine (131I) Drugs Sales Volume by Type
  5. 4.2.1 Global Sodium Iodine (131I) Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Sodium Iodine (131I) Drugs Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Sodium Iodine (131I) Drugs Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Sodium Iodine (131I) Drugs Sales Value by Type
  9. 4.3.1 Global Sodium Iodine (131I) Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Sodium Iodine (131I) Drugs Sales Value by Type (2021-2032)
  11. 4.3.3 Global Sodium Iodine (131I) Drugs Sales Value Share by Type (2021-2032)
5 Sodium Iodine (131I) Drugs Market by Application
  1. 5.1 Sodium Iodine (131I) Drugs Application Introduction
  2. 5.1.1 Diagnosis and Investigation
  3. 5.1.2 Thyroid Cancer
  4. 5.1.3 Hyperthyroidism
  5. 5.2 Global Sodium Iodine (131I) Drugs Sales Volume by Application
  6. 5.2.1 Global Sodium Iodine (131I) Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sodium Iodine (131I) Drugs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Sodium Iodine (131I) Drugs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Sodium Iodine (131I) Drugs Sales Value by Application
  10. 5.3.1 Global Sodium Iodine (131I) Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Sodium Iodine (131I) Drugs Sales Value by Application (2021-2032)
  12. 5.3.3 Global Sodium Iodine (131I) Drugs Sales Value Share by Application (2021-2032)
6 Sodium Iodine (131I) Drugs Regional Sales and Value Analysis
  1. 6.1 Global Sodium Iodine (131I) Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sodium Iodine (131I) Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Sodium Iodine (131I) Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Sodium Iodine (131I) Drugs Sales by Region (2027-2032)
  5. 6.3 Global Sodium Iodine (131I) Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Sodium Iodine (131I) Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Sodium Iodine (131I) Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Sodium Iodine (131I) Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Sodium Iodine (131I) Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Sodium Iodine (131I) Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Sodium Iodine (131I) Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Sodium Iodine (131I) Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Sodium Iodine (131I) Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Sodium Iodine (131I) Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Sodium Iodine (131I) Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Sodium Iodine (131I) Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Sodium Iodine (131I) Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Sodium Iodine (131I) Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Sodium Iodine (131I) Drugs Sales Value Share by Country, 2025 VS 2032
7 Sodium Iodine (131I) Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Sodium Iodine (131I) Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sodium Iodine (131I) Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Sodium Iodine (131I) Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Sodium Iodine (131I) Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Sodium Iodine (131I) Drugs Sales by Country (2027-2032)
  6. 7.4 Global Sodium Iodine (131I) Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Sodium Iodine (131I) Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Sodium Iodine (131I) Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Sodium Iodine (131I) Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Sodium Iodine (131I) Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Sodium Iodine (131I) Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Hta Co., Ltd
  2. 8.1.1 Hta Co., Ltd Company Information
  3. 8.1.2 Hta Co., Ltd Business Overview
  4. 8.1.3 Hta Co., Ltd Sodium Iodine (131I) Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Hta Co., Ltd Sodium Iodine (131I) Drugs Product Portfolio
  6. 8.1.5 Hta Co., Ltd Recent Developments
  7. 8.2 Yantai Dongcheng Biochemicals Co.,Ltd.
  8. 8.2.1 Yantai Dongcheng Biochemicals Co.,Ltd. Company Information
  9. 8.2.2 Yantai Dongcheng Biochemicals Co.,Ltd. Business Overview
  10. 8.2.3 Yantai Dongcheng Biochemicals Co.,Ltd. Sodium Iodine (131I) Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Yantai Dongcheng Biochemicals Co.,Ltd. Sodium Iodine (131I) Drugs Product Portfolio
  12. 8.2.5 Yantai Dongcheng Biochemicals Co.,Ltd. Recent Developments
  13. 8.3 Chengdu Gaotong Isotope Co.,Ltd.
  14. 8.3.1 Chengdu Gaotong Isotope Co.,Ltd. Company Information
  15. 8.3.2 Chengdu Gaotong Isotope Co.,Ltd. Business Overview
  16. 8.3.3 Chengdu Gaotong Isotope Co.,Ltd. Sodium Iodine (131I) Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Chengdu Gaotong Isotope Co.,Ltd. Sodium Iodine (131I) Drugs Product Portfolio
  18. 8.3.5 Chengdu Gaotong Isotope Co.,Ltd. Recent Developments
  19. 8.4 Mallinckrodt
  20. 8.4.1 Mallinckrodt Company Information
  21. 8.4.2 Mallinckrodt Business Overview
  22. 8.4.3 Mallinckrodt Sodium Iodine (131I) Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Mallinckrodt Sodium Iodine (131I) Drugs Product Portfolio
  24. 8.4.5 Mallinckrodt Recent Developments
  25. 8.5 Jubilant Radiopharma
  26. 8.5.1 Jubilant Radiopharma Company Information
  27. 8.5.2 Jubilant Radiopharma Business Overview
  28. 8.5.3 Jubilant Radiopharma Sodium Iodine (131I) Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Jubilant Radiopharma Sodium Iodine (131I) Drugs Product Portfolio
  30. 8.5.5 Jubilant Radiopharma Recent Developments
  31. 8.6 International Isotopes
  32. 8.6.1 International Isotopes Company Information
  33. 8.6.2 International Isotopes Business Overview
  34. 8.6.3 International Isotopes Sodium Iodine (131I) Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 International Isotopes Sodium Iodine (131I) Drugs Product Portfolio
  36. 8.6.5 International Isotopes Recent Developments
  37. 8.7 BWXT Medical Ltd
  38. 8.7.1 BWXT Medical Ltd Company Information
  39. 8.7.2 BWXT Medical Ltd Business Overview
  40. 8.7.3 BWXT Medical Ltd Sodium Iodine (131I) Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 BWXT Medical Ltd Sodium Iodine (131I) Drugs Product Portfolio
  42. 8.7.5 BWXT Medical Ltd Recent Developments
  43. 8.8 Bracco
  44. 8.8.1 Bracco Company Information
  45. 8.8.2 Bracco Business Overview
  46. 8.8.3 Bracco Sodium Iodine (131I) Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Bracco Sodium Iodine (131I) Drugs Product Portfolio
  48. 8.8.5 Bracco Recent Developments
  49. 8.9 AnazaoHealth
  50. 8.9.1 AnazaoHealth Company Information
  51. 8.9.2 AnazaoHealth Business Overview
  52. 8.9.3 AnazaoHealth Sodium Iodine (131I) Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 AnazaoHealth Sodium Iodine (131I) Drugs Product Portfolio
  54. 8.9.5 AnazaoHealth Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sodium Iodine (131I) Drugs Value Chain Analysis
  2. 9.1.1 Sodium Iodine (131I) Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sodium Iodine (131I) Drugs Sales Mode & Process
  6. 9.2 Sodium Iodine (131I) Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sodium Iodine (131I) Drugs Distributors
  9. 9.2.3 Sodium Iodine (131I) Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst